I reckon this is a real high-wire act.
The company will be running on empty by the time the results come in. If the trial is a fizzer, raising cash is going to be very tough indeed.
Suggests to me that management must be supremely confident that the results will be good. Maybe they're picking up some good anecdotal feedback from the trial sites.
Of course, it doesn't mean they're right. This is shaping as the mother of all binary events.
I'm hanging in there. GLTHA
Ann: Neuren receives $0.9m from exercise of last expiring options-NEU.AX, page-6
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$12.96 |
Change
-0.140(1.07%) |
Mkt cap ! $1.612B | |||
| Open | High | Low | Value | Volume |
| $13.20 | $13.36 | $12.82 | $4.627M | 354.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7585 | $12.96 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.03 | 3344 | 2 |
View Market Depth
| Last trade - 16.10pm 16/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |